Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Pharmaceuticals Holding Co., Ltd
  6. Summary
    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

(601607)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
10/19/2021 10/20/2021 10/21/2021 10/22/2021 10/25/2021 Date
18.77 18.7 18.76 18.7 18.78 Last
11756430 8645366 6937369 7536176 5956637 Volume
0.00% -0.37% +0.32% -0.32% +0.43% Change
Estimated financial data (e)
Sales 2021 218 B 34 188 M 34 188 M
Net income 2021 5 387 M 844 M 844 M
Net Debt 2021 13 942 M 2 184 M 2 184 M
P/E ratio 2021 10,0x
Yield 2021 3,13%
Sales 2022 243 B 38 066 M 38 066 M
Net income 2022 5 707 M 894 M 894 M
Net Debt 2022 8 840 M 1 384 M 1 384 M
P/E ratio 2022 9,36x
Yield 2022 3,31%
Capitalization 47 105 M 7 378 M 7 377 M
EV / Sales 2021 0,28x
EV / Sales 2022 0,23x
Nbr of Employees 46 609
Free-Float 60,8%
More Financials
Company
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system,... 
Sector
Drug Retailers
Calendar
10/29Earnings Release
More about the company
Ratings of Shanghai Pharmaceuticals Holding Co., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
08/30Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Half Year En..
CI
08/26SHANGHAI PHARMACEUTICALS : Pharma Successfully Files Application for Share Placement with ..
MT
07/27SHANGHAI PHARMACEUTICALS : Pharma Shareholders to Vote Aug. 12 on $2.2 Billion Fundraising..
MT
07/26SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the extraordinary g..
PU
07/23Shanghai Pharmaceuticals Holding Co., Ltd Announces Executive Changes
CI
07/19SHANGHAI PHARMACEUTICALS HOLDING CO. : Ex-dividend day for final dividend
FA
07/06SHANGHAI PHARMACEUTICALS : The Fortune 500 company Shanghai Pharmaceuticals enters the den..
AQ
07/06Shanghai Pharmaceuticals Holding Co., Ltd acquired Fimet Oy for approximately CNY 200 m..
CI
06/29Shanghai Pharmaceuticals Holding Co., Ltd Approves Cash Dividend for the Year 2020, Pay..
CI
05/27SHANGHAI PHARMACEUTICALS : Pharma to Buy Medical Equipment Maker From Affiliate for Nearly..
MT
05/27Shanghai Industrial Urban Unit to Provide Project Management Services to Shanghai Pharm..
MT
05/27Shanghai Pharmaceuticals Holding Co., Ltd entered into an equity transfer agreement to ..
CI
05/20Shanghai Pharmaceuticals Holding Co., Ltd. Announces Obtaining Acceptance of Applicatio..
CI
05/18CANSINO BIOLOGICS : Bio, Shanghai Pharma Inject $171 Million in Additional Funding into Jo..
MT
05/12SHANGHAI PHARMACEUTICALS : Connected transaction proposed non-public issuance of a shares
PU
More news
News in other languages on SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
2018Ardian lance la vente de l'allemand Riemser Pharma
2017SHANGHAI PHARMACEUTICALS : Vers une cession du fabricant américain de génériques Alvogen
2017Arbor courtisé par deux laboratoires chinois
2017Arbor courtisé par deux laboratoires chinois
2017Insider - Finanzinvestoren geben Stada noch nicht verloren
More news
Chart SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Duration : Period :
Shanghai Pharmaceuticals Holding Co., Ltd Technical Analysis Chart | 601607 | CNE000000C82 | MarketScreener
Technical analysis trends SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 18,78 CNY
Average target price 23,17 CNY
Spread / Average Target 23,4%
EPS Revisions
Managers and Directors
Man Cho President & Executive Director
Bo Shen Chief Financial Officer, Executive Director & VP
Jun Zhou Chairman
Liang Hong Independent Non-Executive Director
Jiang Nan Cai Independent Non-Executive Director
Sector and Competitors